A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Pharmacodynamics of SHR-2010 by Intravenously/Subcutaneously in Healthy Subject
Clinical trial NCT05398510 · COMPLETED
Trial details
- NCT number
- NCT05398510
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-30
- Primary completion
- 2023-03-10
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.